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ANALISIS SIFAT DIOD DOSIMETRI UNTUK DOSIMETRI In-vivo 
DALAM RAWATAN RADIOTERAPI 
ABSTRAK 
Diod adalah merupakan sistem radiasi dosimetri yang digunakan secara 
meluas dalam rawatan radioterapi dan digunakan dalam dosimetri in-vivo. Adalah 
penting untuk memahami sifat pengesan radiasi sebelum ianya digunakan dalam 
rawatan  klinikal. Dalam kajian ini, sifat tiga (3) diod bagi model IBA EDP-153G 
dianalisa dan dibanding dengan kebuk pengionan yang telah dikalibrasi. Pemecut 
linear bertenaga 6 MV digunakan dengan membandingkan saiz bidang, jarak sumber 
ke pengesan, unit monitor, tray, baji dan bacaan diod di belakang cerroband. 
Ketebalan sebenar diode, kebolehan bacaan berulang, kesan radiasi di bawah diod, 
kesan diod dengan perbezaan sudut radiasi dan kesan suhu terhadap diod juga 
dilakukan. Daripada penentuan sifat diod dosimetri ini, sistem perancangan 
berkomputer klinikal dan kebuk pengionan yang telah dikalibrasi digunakan untuk 
mengesahkan ketepatan bacaan diod dalam pelbagai teknik rawatan. Hasil kajian 
mendapati diode EDP-153G adalah sensitif terhadap sudut radiasi, baji, jarak sumber 
radiasi dan suhu. Sudut yang diukur untuk diod adalah kurang daripada 2% pada 
sudut ± 41 °, ± 37 ° dan ± 72 ° untuk diod 1, diod 2 dan diod 3. Didapati bahawa 
faktor pembetulan SSD meningkat selari dengan pertambahan SSD. Faktor 
pembetulan SSD dari SSD 75 cm ke 140 cm bagi diod 1 ialah 0.995 - 1.025, cm bagi 
diod 2 ialah 0.975 - 1.046 dan cm bagi diod 3 ialah 0.989 - 1.021. Faktor pembetulan 
baji adalah meningkat selari dengan peningkatan sudut baji. Faktor pembetulan baji 
bagi diod 1 ialah 1.003 - 1.023, bagi diod 2 ialah 1.009 - 1.033 dan bagi diod 3 ialah 
1.011 - 1.056. Perbezaan purata peratus yang diukur dan suhu sisihan piawai bagi 
xv 
diod 1, 2 dan 3 ialah 0.53 ± 0.19% / ° C, 0.56 ± 0.16% / ° C dan 1.02 ± 0.33% / ° C. 
Didapati bahawa setiap diod mempunyai sifat yang berbeza dan perlu dianalisis 
secara berasingan. Penggunaan diod terhadap pesakit tanpa pemahaman yang jelas 
akan memberikan bacaan yang salah. Daripada simulasi phantom yang dilakukan 
dengan menggunakan teknik kalibrasi dan faktor pembetulan yang betul bacaan ± 




DIODE DOSIMETRIC CHARACTERISATIONS AND ASSESSMENTS 
FOR In-vivo DOSIMETRY IN RADIOTHERAPY TREATMENT 
ABSTRACT 
Diode is a kind of radiation dosimetry system that has been applied widely in 
radiotherapy treatment and very useful for in-vivo dosimetry (IVD). It is duly 
important to understand the characteristic of detector before it can be used in clinical 
treatment. In this study, characteristics of three (3) diodes IBA EDP-153G model were 
analyzed and compared to calibrated ionization chamber. The 6 MV linear 
accelerator (Linac) was used with different field sizes (FS), source to surface 
distance (SSD), linac monitor unit (MU), tray field (TF) wedge field (WF) and diode 
reading behind cerroband. Actual diode thickness, diode reproducibility, perturbation 
effect and diode effect with radiation beam angle and temperature were performed. 
From the determination of diode dosimetric characteristic, a clinical computerized 
treatment planning system (TPS) model Elekta Monaco and calibrated ionization 
chamber were used to verify the accuracy of diode reading in different treatment 
techniques. In this study, EDP-153G diode was sensitive with angle of incidence, 
wedge, SSD and temperature. The measured angle for diode were less than 2 % at 
angle ± 41°, ± 37° and ± 72° for diode 1, diode 2 and diode 3 respectively. SSD 
correction factors have increased proportionally by increasing the SSD. SSD 
correction factor from SSD 75 cm to 140 cm 0.995 to 1.025, 0.975 to 1.046 and 
0.989 to 1.021 for diode 1, diode 2 and diode 3 respectively. Wedge correction 
factors have increased proportionally by increasing the wedge angle Diode wedge 
correction factor resulted in the range of 1.003 to 1.023, 1.009 to 1.033 and 1.011 to 
1.056 for diode 1, diode 2 and diode 3 respectively. The measured average 
xvii 
percentage difference and standard deviation temperature for diode 1, 2 and 3 were 
0.53 ± 0.19 %/°C, 0.56 ± 0.16 %/°C and 1.02 ± 0.33 %/°C respectively. Each diode 
has their own characteristics and should be analysed individually. The use of diodes 
to patients without clear understanding will give false reading. From the observation 
of phantom simulation results, it can be concluded that by applying proper 
calibration and correction factors, ± 3% reading is achievable for standard treatment 








CHAPTER 1  
 
INTRODUCTION 
1.1 Background research 
Radiotherapy is a one of modality for treating cancer patients. Radiotherapy 
can be used alone or in combination with chemotherapy. Almost half of cancer 
patients have undergo radiotherapy as part of their treatment plan. Radiotherapy is 
also delivered to treat benign (not malignant) tumour and others condition, for 
example blood disorders. 
A LINAC is a device that most commonly used in radiotherapy. In current 
practice, LINAC comes with specific TPS. All machine data will be entered into 
TPS. A set of data was collected by using 3-D water phantom and also entered into 
TPS. A set of data depends on type of TPS and algorithm being used. Data 
verification will be carried out after that to confirm machine is ready for clinical 
works. 
In normal practice, beam data verification need to be performed before 
implementing start clinical work and whenever the software and hardware being 
updated or upgraded. In some cases, like Intensity Modulated Radiation Therapy 
(IMRT) planning technique, TPS verification or patients’ specific QC will be carried 
out prior to the treatment. During treatment, no specific dosimetry QC for patients 
will be done.  
In-vivo dosimetry (IVD) is an important method to monitor and compare dose 
measured from the detector such as diode with the theoretical values, as calculated 
by TPS or manual calculation. IVD is also a tool for the detection of  set-up error 
during radiotherapy treatment. Currently in the market, many methods of 
2 
measurements can be used for IVD such as diode, TLD and film. Diode gives an 
advantage compared to others due to it enables to give an immediate reading during 
treatment. 
A silicon diode dosimeter is designed with p-n junction and referred as n-Si 
or p-Si depending on base material (Izewska and Rajan, 2005). An n-type diode is 
formed by doping acceptor impurities into a region of n-type silicon. A p-type diode 
is formed by doping donor impurities into a p-type substrate (AAPM, 2005). Institut 
Kanser Negara (IKN) has a p-type diode, model EDP-153G. End of model number 
has referred to water equivalent build-up in mm.  
1.2 Problem statement 
The International Commission of Radiation Units and measurements (ICRU) 
has recommended an overall accuracy in dose delivery of ±5% (ICRU, 1976) based 
on an analysis of dose response data and an evaluation of errors in dose delivery. 
This is very important to achieve good treatment outcome. IVD is an important tool 
to monitor patient’s actual reading when receiving the treatment.   
IKN posses a new p-type diode detector of in-vivo dosimetry (IVD) system, 
model IBA system. Before the system can be used for clinical, fully understanding of 
diode characteristics is great important. All standard radiotherapy parameters during 
treatment will be taken into consideration for analysing diode characteristics to 
achieve a high level of accuracy. 
This study also provides a suggestion to start IVD programme in clinical 
setting.  IKN will be getting a good benefits’ from this study. 
3 
1.3 Objectives of research 
The objectives of this thesis are: 
1. To identified/investigate diode characteristics and to understand its capabilities 
and limitation to be used as IVD in radiotherapy treatment. This characterization 
will give guidance on correction method and evaluate its efficacy. 
2. To validate diode reading with patient simulation. It will be tested with rando / 
CIRS phantom as a method of verification and compared with TPS as well as IC. 
1.4 Research scope 
In this research, a total of 5 phases studied were conducted. First phase 
research was the study of diode characteristics in external beam radiotherapy. In 
phase 2, study has been focused on comparison of diode, IC and TPS in standard 
treatment. Thorax phantom image model CIRS002LFC was obtained from CT 
Simulator and planned with TPS model Monaco, Elekta. Phase 3 study was 
performed in order to simulate the real clinical cases in standard treatment. Phase 4 
study focused on TBI data collection and diode characteristics. Phase 5 study was 
performed on the application diode in special treatment TBI. Since TBI treatment has 
not been started in IKN, suggestion of treatment technique was needed and relevant 
data was collected. Study has been focused to 6 MV energy due to diode thickness 
equivalent to  1.5 cm equivalent with 6 MV dmax. Furthermore, 6 MV is the practical 
energy used in most cases. 
4 
1.5 Clinical significance / Significance of the study 
By conducting this research, the study of the diode characteristics will be 
fully understood. High accuracy of diode reading during measurement will be 
achieved and will be beneficial to the patients in terms of clinical outcome.  
1.6 Thesis Organizations 
This thesis is structured into 5 chapters. Chapter 1 briefly describes about the 
background, problem statement, objectives of research, the scope of the study, 
clinical significance / Significance of the study  and how the dissertation is being 
organized. 
Chapter 2 presents the literature review on diode theoretical aspect, 
radiotherapy treatment and the related studies that had been carried out in this field. 
Chapter 3 focuses on research methods that were implemented throughout this study.  
 The results and discussion are then presented in Chapter 4. The conclusion 
and suggestion for further works are given in Chapter 5. This Chapter is followed by 




CHAPTER 2  
 
THEORY AND LITERATURE REVIEW 
2.1 Introduction 
Dosimetry is great significant in radiotherapy. For a better treatment, radiation 
dose to patients should receive as prescribed by Oncologist. Radiotherapy treatment is 
a comprehensive workflow where patient will undergo preparation of immobilization,  
imaging acquisition includes CT, MRI, PET images and others if required,  target and 
organ at risk delineation, manual or computerized TPS, IGRT, treatment delivery and 
routine follow up.  
Throughout the workflow, periodic routine QC for LINAC, CT Simulator, 
computerized TPS and others have been performed to ensure that all machines are 
capable to give a better accuracy and safety during patients treatment. In additional, 
software updates and hardware upgrades are also being carried out from time to time. 
Sensitivity of machine with environment also contributes a major factor in order to 
achieve a high accuracy treatment delivery. Involvement of dedicated staffs during all 
this process is utmost important. 
There are many processes in radiotherapy from patient simulation to treatment 
and  each  process may introduce an uncertainty errors (Thwaites et. al., 2005). IVD is 
the only way to monitor actual doses received by the patients during treatment. 
Understanding of IVD characteristcs is crucial before it can be used in clinical. 
2.2 Radiation dosimetry 
A radiation dosimeter is an instrument to measure ionising radiation. There are 
many types of dosimeters where it has capability to measure either directly or 
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indirectly and besides proper calibration is needed (Izewska and Rajan, 2005). The 
choice of a radiation dosimeter and its reader must be made with caution, taking into 
account the needs of the measurement situation. Ionisation chambers are 
recommended for beam calibrations and other dosimeters, such as film, TLD and 
diode are appropriate for the analysis of the dose distribution  or  point dose 
verification (Izewska and Rajan, 2005). 
2.2.1 Properties of dosimeters 
2.2.1(a) Accuracy and Precision  
The precision of dosimetric measurements specifies the reproducibility of the 
measurements under similar conditions and can be estimated from the data obtained in 
repeated measurements evaluated as the standard deviation of the measurement 
results. The accuracy of dosimetric measurements is the proximity of their expectation 
value to the ‘true value’ of the measured quantity (Izewska and Rajan, 2005). 
2.2.1(b) Linearity  
Preferably, the dosimeter reading linearly proportional to the dosimetric 
quantity is ideal but beyond a certain dose range a non-linearity sets in. The linearity 
characteristics depend on the physical characteristics of the dosimeter. Figure 2.1 
shows samples of linearity characteristics of typical dosimetry systems. Curve A first 
exhibits linearity with dose, then a supralinear behaviour, and finally saturation. Curve 
B first exhibits linearity and then saturation at high doses. Generally, a non-linear 























Figure 2.1 Linearity characteristics of two dosimetry systems. (Izewska and 
Rajan, 2005) 
 
2.2.1(c) Energy dependence  
The response of a dosimetry system is generally a function of radiation energy. 
Normally dosimetry systems are calibrated at a specified radiation energy and used 
over a much wider energy range, the variation of the response of a dosimetry system 
requires additional correction. (Izewska and Rajan, 2005). 
2.2.1(d) Directional dependence  
Directional dependence is referred to dosimeter respond with the angle of 
incidence of radiation. Dosimeters generally  exhibit directional dependence, because 
of their design and physical  size. LINAC calibration using ionization chamber is used 
in the same set-up as that in which they are calibrated. Directional dependence is 





2.2.1(e) Spatial resolution and physical size  
Each dosimetry has different capabilities depends on physical size and spatial 
resolution. In radiotherapy, ionisation chamber is suitable for calibration. Film 
dosimeters have excellent 2-D and gels 3-D resolution, where the point measurement 
is limited only by the resolution of the evaluation system. TLD and diode come in 
very small dimensions and suitable for point dose measurement (Izewska and Rajan, 
2005).  
2.2.1(f) Readout convenience  
Direct reading dosimeters are generally simple and convenient than passive 
dosimeters. Ionization chamber or diodes are referred to direct reading where TLDs 
and film referred to passive dosimetry. TLDs and film required specifics procedure 
before the actual reading is obtained (Izewska and Rajan, 2005). Immediate action or 
correction can be done for direct reading dosimeter compared to passive dosimeters. 
2.2.1(g) Convenience of use  
Ionization chambers are reusable and no or little change in sensitivity within 
their lifespan makes it suitable for calibration of radiotherapy equipments. 
Semiconductor dosimeters are reusable, but with a gradual loss of sensitivity within 
their lifespan. Films and gels are not reusable. Some dosimeters measure dose 
distribution in a single exposure like films and gel. In terms of handling some 
dosimeters are quite rugged (for example IC), while others are sensitive to handling 
(like TLDs) (Izewska and Rajan, 2005). 
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2.2.2 Type of dosimetry 
Radiation dosimetry systems come in many design and function. The 4 most 
commonly used radiation dosimeters are IC, radiographic films, TLD and Diode. The 
advantages and disadvantages of these 4 dosimeters are summarized in Table 2.1. 
Table 2.1 Advantages and disadvantages of the four frequently used dosimetric 





































2.2.3 In-vivo dosimetry (IVD) 
There are many steps in radiotherapy treatment from simulation to treatment 
delivery and each of these steps may introduce uncertainties (Thwaites et. al.,  2005). 
Specific patient groups or unusual treatment conditions might be crucial be given as a 
final check of the actual treatment by using IVD. In-vivo dose measurements can be 
used for entrance dose measurements serve to check the treatment  machine output 
and performance as well as the accuracy of patient set-up (Thwaites et. al., 2005). In-
vivo dosimetry also capable to determine the intracavitary dose in readily accessible 
body cavities such as the oral cavity, bladder and rectum by using special in-vivo 
detector design (Izewska and Rajan, 2005; Van Dam and Marinello, 2006). 
In-vivo dose measurements can be applied to check the dose delivery to the 
target volume and dose to organs at risk (e.g. lungs during TBI) or in situations in 
which the dose is difficult to foresee (e.g. non-standard SSD) (Thwaites et. al., 2005). 
If entrance dose measurements are applied, the entrance dose has to be calculated 
manually to the corresponding target dose using treatment set-up details (Thwaites et. 
al., 2005). 
2.3 Diode Dosimetry 
2.3.1 Theory of diode 
Important elements in the silicon diodes used for in-vivo dosimetry is the p-n 
junction. A p-n junction is an internal boundary between p-type and n-type regions in 
a single crystal. Diodes are termed n-type or p-type depending upon whether the 
silicon substrates are doped with phosphorous (where majority-carriers are electrons) 
or boron (where majority-carriers are holes). An n-type diode is formed by doping 
acceptor impurities into a region of n-type silicon pentavalent (group V) element (e.g., 
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phosphorous) called a “donor.” Each donor can contribute a free electron to the 
silicon. Therefore, the majority carriers in n-type silicon are electrons, and holes are 
the minority carriers. (AAPM, 2005; IAEA, 2013). 
A p-type diode is formed by doping donor impurities into a p-type substrate 
with trivalent (group III) element (e.g., boron) called an “acceptor.” Each acceptor can 
accept an electron, resulting in a mobile hole in silicon that is equivalent to a 
positively charged carrier. In p-type silicon, holes are the majority carriers while 
electrons are the minority carriers . (AAPM, 2005; IAEA, 2013). 
At the transition from p- to n-type material, a charge-free “depletion layer” is 
formed, over which an electrostatic potential difference is created (about 0.7 V for a 
silicon diode). As a result an electric field (E) is created over the depletion layer 
(Figure 2.2). By contrast to most other applications in electronics, in dosimetry no 
external bias is applied to the diode, which is then used in the “unbiased” or “short-









Figure 2.2 Theory of diode detection in short-circuit mode. (Van Dam and 
Marinello, 2006) 
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When the diode is irradiated, an ionisation “electron-hole” pair may be created 
in the depletion layer (Figure 2.2). The electrons and holes are attracted by p- and n-
sides of the junction, respectively. Due to the high doping level at the n-side of a p-
type diode, a lot of crystal imperfections or “recombination centres” are present at that 
side, which leads to a high probability of recombination for the holes. So only the 
minority charge carriers, electrons in this case, contribute to the ionisation signal. Due 
to this process the charge equilibrium between n- and p-sides of the diode is disrupted 
by the radiation. When connecting both sides externally to each other, a current will 
be detected at radiation, which, when the diode is in the unbiased mode, is 
proportional to the number of electron-hole pairs produced, i.e. to the dose (AAPM, 
2005; Van Dam and Marinello, 2006; IAEA, 2013) 
Diodes for dosimetry are function without an external reverse bias voltage to 
minimize leakage and can be measured in short circuit mode (current) or open circuit 
mode (voltage). Short circuit mode is the mode of choice since it has the benefit of 
producing a linear relationship between the charge generated in the diode and the 
dose. In short circuit mode, shown in figure 2.3, the electrometer must have low 
dynamic input impedance, as provided by an operational amplifier with a feedback 
loop and a low offset voltage as the diode signal is quite high, the electrometer used 
only needs to have moderate gain. It is common for diode systems to have a 












Figure 2.3 Diode measurement circuit (IAEA, 2013). 
2.3.2 Characteristics of diode 
The response of the diode in a current mode is complex and can be affected by 
dose rate, temperature, radiation and material. Changing the dose rate of ionising 
radiation effects the injection level and recombination properties of charge carries in a 
base of the detectors. Long term irradiation of the diode during the clinical or in vivo 
is leading to accumulation of radiation defects and reducing of diffusion length and as 
a result sensitivity of the detector. Changing of temperature affects recombination 
activity and response of the diode (Rosenfeld, 2006). 
2.3.2(a) Temperature effects and accumulated doses.  
The sensitivity of diode usually increases with temperature because internal 
resistance of a diode decreases (Van Dam et. al., 1990; Jornet, et. al., 1995). The 
diode required 2 to 3 minutes to reach a stable state with approximately 32°C  when it 
is placed on a patient. The diodes should be left to reach body temperature for at least 
3 minutes before the measurement is begun if the sensitivity variation found to be 
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significant. Then, correction is made for the difference in temperature between 
calibration and measurement (IAEA, 2013). No temperature correction is needed for 
in-vivo dosimetry if it remains smaller than 0.4% per °C.  (Van Dam and Marinello, 
2006). Diode also depends on the accumulated dose received by the diode (IAEA, 
2013). 
2.3.2(b) Background signal.  
If the background signal of the diode is varied by 4 mGy/min between room  
and body temperature,  the diode will generate a dark current due to thermally 
generated charge carriers. To get the satisfactory background measurement, several 
minutes are needed to disturb the equilibrium of the circuit as well as may cause a 
change in diode response. (IAEA, 2013). 
2.3.2(c) Radiation damage.  
Radiation damage occurs when silicon atoms are displaced from their lattice 
sites and introduces recombination centres which capture charge carriers leading to 
the reduction in sensitivity and to an increase in dose rate dependence. P-type diodes 
are commonly less affected by radiation damage compared with n-type diodes. The 
amount of damage also depends with radiation energy (IAEA, 2013).  
2.3.2(d) Energy dependence.  
Silicon is not equivalent with human tissue. Different types of material used to 
provide equivalent build-up to make it suitable with specifics energy. The response of 
a diode should be measured as a specific energy and particular attention should be 
paid when measuring outside the field or under shielding blocks, because of the large 
spectral differences with in-field positions (Van Dam and Marinello, 2006). 
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2.3.2(e) Angular dependence.  
Diode is designed with reference to clinical application needed. Most of  cases, 
diodes will be positioned perpendicular to the radiation and thus correction factors can 
be ignored (IAEA, 2013). Directional dependence of diode response for large angle 
should be taken into consideration for example in case of tangential irradiation of the 
breast (Van Dam and Marinello, 2006). 
2.3.2(f) Signal stability after irradiation.  
The stability of the reading which is displayed after irradiation should be 
checked for time periods corresponding to those encountered in clinical practice. The 
drift should not exceed 1% in 1 hour when used for conventional treatments. For 
particular applications such as integration of the dose during total body irradiation 
performed at low dose-rate, the checks should be extended to a period of several hours 
(Van Dam and Marinello, 2006).  
2.3.2(g) Intrinsic precision.  
The intrinsic precision is given by the reproducibility of the measurements for 
at least 10 times irradiations at the same dose. The standard deviation should not 
exceed 1% (Van Dam and Marinello, 2006). 
2.3.2(h) Influence of dose-rate.  
During the irradiation, electron-hole pairs are formed at a rate which increases 
as a function of dose rate. If this dose rate is high a phenomenon of “pile up” occurs 
where ions are produced at such a high rate that the recombination cannot “keep pace” 
and more charge carriers escape recombination compared with lower dose rates. The 
dose rate dependence of a diode should be taken into account for LINACs, but may be 
ignored for cobalt and TBI conditions. Dose rate at the LINAC machine can be 
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adjusted from low to high according to the machine specifications. Normally high 
dose rate will be used in clinical setting to speed up the treatment time. The diode 
should be calibrated in the dose rate range in which it will be used in clinical 
treatments (Van Dam and Marinello, 2006). 
2.4 Calibration procedure 
2.4.1 Entrance 
Before diode can be used clinically, diode should be calibrated against IC. In 
radiotherapy, absorbed dose to water was calibrated using IC (Almond et. al., 1999; 
IAEA, 2000b). Calibration of diode against an IC in standard set-up to get diode 
calibration coefficient for absorbed dose to water, Ncal. IAEA (2013) proposed 
calibration method for photon as Figure 2.4. 
 
Figure 2.4 Set-up of in-vivo dosimeters for photon calibration  
 (IAEA, 2013). 
 
The calibration was carried out with the IC was placed at the reference depth, 
standard set-up (SSD 100 cm and FS 10x10 cm2) and preferred using solid water 
phantom. The diodes were positioned at phantom surface near to the central beam 
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axis.. The dose measured by the IC must therefore be increased according to the PDD 
at the measurement depth.  
The irradiation of treatment machine was set to deliver D0 = 200 cGy at dmax. 
The actual delivered dose was measured with the IC at the reference depth and was 
calculated following the established protocol (IAEA, 2013) like IAEA TRS-398 Code 
of Practice (IAEA, 2000) and AAPM TG-62 (Almond et. al., 1999). The diodes 
calibration was equal to the dose at dmax in water. 
 








. kpl                                       (2.1) 
                                    
where 
D0 = D/(PDD/100), 
M is the in-vivo dosimeter reading, 
and kpl is the plastic to water correction. kpl is defined in equation 2.4. 
 
In order to minimize any subsequent SSD correction factor, a specific SSD 
correction should applied. The dosimeter reading was multiplied by equation 2.2 for 
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where ds is the distance from the surface of the phantom to the centre of the sensitive 
volume of the dosimeter. 
 
If a solid non-water phantom was used for calibrations, additional correction 




=                                                           (2.3) 
where Mw, Mpl are the chamber readings corrected for temperature and pressure, and 
Dw and Dpl are the absorbed dose to water at dmax or specifics depth in water and in 
plastic, respectively. The final equation is given by: 
 
k =  
M
M  ×  
P
P  × 
T  + 273
T +  273                                                (2.4) 
 
Where Mw and Mpl are the chamber corrected readings in water and in plastics 
respectively. Pw and Ppl are the preasure readings in water and in plastics respectively. 
Tw and Tpl are the temperature readings in water and in plastics respectively. 
2.4.1(a) Entrance dose measurement at dmax  
Entrance dose reading at dmax, D normally referred to depth of maximum dose. 
Actual IVD reading is calculated with calibration coefficient and all correction factors 
related for each individual beam: 
 
D = M ×  N  ×  ∏ k                                             (2.5) 
 
where ki are the related correction factors (IAEA, 2013). For example, equation 2.6 
required angle of incidence, SSD, wedge and FS correction factor.  
 
D = M ×  N  × 
SSD −  d




2.5 Clinical application of In-vivo Dosimetry 
IVD  has been applied in clinical application with  many purposes. First is to 
measure dose at organs at risk. Second is to verify treatment set-up and errors in the 
treatment and accessories. Entrance dose measurements are also capable to detect 
errors in the dose calculation especially with manual calculation (IAEA, 2013).  
2.5.1 TPS Verification 
Now days all commercial radiotherapy TPS is able to calculate point expected 
absolute dose at depth at dmax for every beam. IVD measurement can be used to verify 
each beam one by one. These methods also enable to estimate any doses below the 
diode dosimetry such as target dose or organ at risk (IAEA, 2013). 
2.5.2 Total Body Irradiation 
TBI is a special radiotherapy technique that delivers to a patient’s whole body 
a dose uniform to within ±10% of the prescribed dose. Photon beams are used for this 
treatment with large fields to cover whole body except for a organ at risk, which are 
partially or fully shielded (Podgorsak, 2005). 
TBI is used primarily as part of a preparatory cytoreductive conditioning 
regimen prior to bone marrow transplantation (BMT). The source of marrow may be 
the patient (autologous transplant), an identical twin (syngeneic transplant) or a 
histocompatile donor (allogeneic transplant). Figure 2.5 shown establish technique for 





































Figure 2.5 TBI treatment techniques: (a) Parallel opposed beams, (b) dedicated 
cobalt unit, (c) Patient standing (Extended SSD) (d) Patient on a 
stretcher (Extended SSD) (Podgorsak, 2005). 
The TBI dose is prescribed or normalised to body isocenter and usually 
umbilicus is the reference point. The TBI treatment should deliver the prescribed dose 
to the dose prescription point and should maintain the dose throughout the body 
within ±10% of the prescription point dose. Uniformity of dose is able to achieve with 
the use of bolus or compensators (Podgorsak, 2005). 
Once TBI technique has been selected, commissioning procedure should be 
carried out and dosimetric data for TBI like absolute beam output calibration and PDD 
will be collected. The requirements for accurate dose delivery in TBI are as stringent 
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as those in standard external beam radiotherapy. It is important that in departments 
delivering TBI in-vivo dose measurement techniques be available to verify the patient 
dose directly during the treatment (Podgorsak, 2005). 
2.6 Previous research done for diode dosimetry 
Table shown study was done in previous study related with diode 
characteristics. 





1 Temperature Changing of temperature affects recombination activity and 
response of the diode (Rosenfeld, 2006). Most of the 
previous study the diode response was found to increase 
with temperature. 
Ozleyis Altunko et. al. (2015) demonstrated that 
temperature correction factors EDP-5 and EDP-10 were 
found from slope of the linear drawings for each diode 
types. These factors for EDP-5 and EDP-10 were 0.29 
%°C/cGy and 0.30 %°C/cGy respectively. While the more 
fluctuation for EDP-20 was realized.  
Van Dam et. al. (1990) study showed between 20°C and 
30°C the diode response was found to increase linearly with 
temperature range between 1.00 and 1.07 
Nilsson, et. al. (1988) study shown diode (EDP-8, EDP-10) 
response using photon with different temperature had 
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shown that a steady state situation with an increase in 
response of 2-3% is obtain after 3-4 min. 
Zhu (2000) did not apply any correction for temperature 
because the treatment time was less than 1 minutes. 
Leunens and Schueren (1990) study showed with only about 
10s between taping of the detector and treatment time 1 
min, it was suggested not to correct for temperature. 
2 Dose rate 
 
Changing the dose rate of ionizing radiation effects the 
injection level and recombination properties of charge 




Huang, et, al., (2003) study using IVD Model 1131 (Sun 
Nuclear Corporation, Melbourne, FL) showed that silicon 
diode detectors (Isorad-p diode and QED p-type diode 
Detectors) with 6 MV and 18 MV was decreased with 
decreasing SSD in range between 0.93 to 1.04. 
Meiler and Podgorsak (1997) study using Isorad detectors, 
Nuclear Associates, Carle Place, NY showed that increasing 
SSD for a fixed collimator setting results in decreased diode 
response up to 10%. 
4 Field Size. 
 
Huang, et, al., (2003) study showed most of diode was 
increased with increase in field size except for QED diode, 
4 MV and 10 MV. 4 MV diode showed the opposite 
behavior where DCF diode decreased with increase of field 
size. This is due to insufficient buildup. For the 10 MV 
diode the DCF roughly remained a constant when field size 
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changed.  
Nilsson, et. al. (1988) analysis diode (EDP-8, EDP-10) 
response using photon with different open field sizes is 
within 1%. 
5 Directional  
 
Nilsson, et. al. (1988) studied diode (EDP-8, EDP-10) 
response using photon with directional dependence shown 
variation of 10% with different angle of incidence.  
6 Blocking 
Filter 
Nilsson, et. al. (1988) study diode (EDP-8, EDP-10) 
response using photon with blocking filter is within 2%. 
7 Wedge 
 
Nilsson, et. al. (1988) study diode (EDP-8, EDP-10) 
response using photon with wedges was 3-6% 
Fontenla et. al., (1996) study diode EDP-20 showed the 




Nilsson, et. al. (1988) study diode profile measurement 
(EDP-8, EDP-10) where diode will act as a build-up 
material and thus increase the surface doses. Surface doses 
were very much increased and were more than 90% of 
maximum doses. The attenuation effect at 5 cm depth give a 
reduction of 5% over an area 1 cm2. 
9 Diode built-
up 
Fontenla et. al. (1996) study measured built-up cap for 
EDP-10 and EDP-20 were 4 mm and 13 mm respectively. 








3.1.1 In-vivo Dosimetry (IVD) System 
 
(a)                                                    (b) 
                                                 
Figure 3.1 IBA  In-vivo dosimetry system  (a) DPD-12pc Electrometer (b) Mobile 
detector support system and EDP-153G diode. (Courtesy IKN, 2016). 
 IVD is an essential element in the quality assurance for radiotherapy 
department. This system has capability to measure up to 12 channels in a single 
measurement. Omni Pro InViDos is an IVD software management system which 
handles all task of in vivo dosimetry. With 12 channels, this system has the ability for 
a wide variety of applications such as entrance dose measurement and total body 
irradiation measurement. Diode model EDP-153G was used for this study and 3 diodes 
were studied with serial number 10415, 10434 and 10435. This diode has a p-type 
semiconductor. Diode connected to a DPD-12pc (Scanditronix, Sweden) electrometer. 
All diode were mounted on the mobile detector support system. The build-up cap 
Electrometer 
Mobile detector 
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Diode 
